Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MDVN > SEC Filings for MDVN > Form 8-K on 31-Jan-2014All Recent SEC Filings

Show all filings for MEDIVATION, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for MEDIVATION, INC.


31-Jan-2014

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events.

On January 28, 2014, Medivation Inc. and Astellas Pharma Inc., Medivation's collaboration partner, issued a joint press release announcing final results on the primary and secondary efficacy endpoints from the Phase 3 PREVAIL trial. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference, and a copy of select slides relating to the final results on the primary and secondary efficacy endpoints from the Phase 3 PREVAIL trial are attached hereto as Exhibit 99.2 and are incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

Exhibit
Number                                    Description

99.1         Joint press release dated January 28, 2014, announcing final results
             on the primary and secondary efficacy endpoints from the Phase 3
             PREVAIL trial.

99.2         Select slides relating to the final results on the primary and
             secondary efficacy endpoints from the Phase 3 PREVAIL trial.


  Add MDVN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MDVN - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.